Elon Musk has said that the first person to receive the Blindsight version of Neuralink will be treated this year.

Neuralink received a US FDA approval for the Blindsight chip in September 2024. It was designated as a ‘breakthrough device’.

Long before Elon Musk was launching rockets and leading Tesla (NASDAQ:TSLA), he was a rising entrepreneur with a very specific vision for the life he wanted—and the woman he wanted beside him. Justine ...

Blindsight received ‘breakthrough’ status from the US Food and Drug Administration (FDA) in September last year. It has been ...

The US Food and Drug Administration (FDA) granted Blindsight a ‘breakthrough’ status last year in September. This tag is ...

Discover how Elon Musks handpicked experts at the Department of Government Efficiency (DOGE) are tackling fraud, digitizing ...

Discover Elon Musk ambitious plans for Mars, with SpaceX's Starship aiming for a 2026 landing. Unity and innovation drive this vision.

Elon Musk's startup, Neuralink, plans to implant its artificial visual prosthesis, 'Blindsight', in a human for the first time by late 2025.

The sale comes at a time when both X and xAI are undergoing major transformations. Since acquiring Twitter for $44 billion in 2022, Musk has reshaped the platform by implementing controversial ...

New Dems' vision for the path forward is grounded on three pillars: economic growth and lowering costs, healthy and safe ...

According to Musk, Blindsight is designed to allow those who have lost both eyes and their optic nerve to see and even enable ...